Drug intelligence / Profile preview

Compound Houttuynia Cordata Tablets

Development stage
Unknown
Lead developer
Guangdong Xinfeng Pharmaceutical Industry
Modality
Small Molecules
Administration
Oral
01

Overview

Compound Houttuynia Cordata Tablets (Fufang Yuxingcao Pian) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Guangdong Xinfeng Pharmaceutical. It is an approved over-the-counter (OTC Class A) medication in China, indicated for the treatment of respiratory conditions such as acute pharyngitis and acute tonsillitis caused by external wind-heat. The formulation consists of five primary herbal ingredients: *Houttuynia cordata* (yuxingcao), *Scutellaria baicalensis* (huangqin), *Isatis root* (banlangen), *Forsythia* (lianqiao), and *Lonicera japonica* (jinyinhua). According to TCM principles, the drug functions to clear heat and detoxify, addressing symptoms like throat redness, swelling, and pain. As a complex herbal mixture, it does not have a single identified molecular target but relies on the synergistic effects of its botanical components.

Brand names
XinfengXianfeng
Other names
Fufang Yuxingcao Pian复方鱼腥草片Compound Yuxingcao PianCompound Houttuynia tablets
02

Targets

MMP9 (Matrix metalloproteinase-9)IL-6 (Interleukin 6)RdRp (Coronavirus RNA-dependent RNA polymerase)RELA (Nuclear Factor Kappa B Subunit p65)Mpro (3C-like proteinase of SARS-CoV-2)PGE2 (Prostaglandin E2)MMP1 (Matrix metalloproteinase-1)MMP3 (Matrix metalloproteinase-3)

Beyond the preview

Go deeper on Compound Houttuynia Cordata Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Houttuynia Cordata Tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call